New perspectives on metabolic (dysfunction) associated fatty liver disease

Fatty liver disease is a condition characterized by a build-up of fat in the liver and is the most common chronic liver disease that affects over one billion people. Over time, this can lead to complications including cirrhosis, liver failure, liver cancer, and heart health issues. The disease is now known as metabolic (dysfunction) associated fatty liver disease (MAFLD). This is because the disease is now understood to be linked to metabolic factors, such as obesity, insulin resistance, and diabetes.

FORMER PS CHALWE LOMBE’S VEHICLE CARRIES US$4.6M – WITNESS

By LUCY PHIRI 

A FORMER legal counsel at the Ministry of Foreign Affairs has told the Lusaka Magistrate Court that the late former Ambassador to Turkey, Joseph Chilengi instructed the release of US$4.6 million for the purchase of the chancery.

This content is locked

This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.


Tests find many popular omega 3 supplements are rancid

Many consumers buying over-the-counter omega-3 fatty acid supplements may be getting rancid pills, according to a new study published Sept. 7 by researchers at the George Washington University. Derived from plants (algae) as well as seafood (fish, krill, etc.) , omega-3 supplements—sometimes labeled as fish oil—are often taken because of research that suggests they may provide health benefits.